Restored phagocytic ability of RPE patches derived from gene-corrected retinitis pigmentosa-hiPSCs on a biodegradable scaffold via clinical-grade protocol: Implications for autologous therapy
Status PubMed-not-MEDLINE Jazyk angličtina Země Nizozemsko Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
40808876
PubMed Central
PMC12343362
DOI
10.1016/j.gendis.2025.101609
PII: S2352-3042(25)00098-4
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Department of Ophthalmology Oslo University Hospital Oslo 0450 Norway
Karl Landsteiner Institute for Retinal Research and Imaging Vienna 1030 Austria
Ocular and Stem Cell Translational Research Section National Eye Institute NIH Bethesda MD 20892 USA
Zobrazit více v PubMed
Lukovic D., Artero Castro A., Delgado A.B., et al. Human iPSC derived disease model of MERTK-associated retinitis pigmentosa. Sci Rep. 2015;5 PubMed PMC
Artero Castro A., Long K., Bassett A., et al. Generation of gene-corrected human induced pluripotent stem cell lines derived from retinitis pigmentosa patient with Ser331Cysfs∗5 mutation in MERTK. Stem Cell Res. 2019;34 PubMed
Sharma R., Bose D., Montford J., Ortolan D., Bharti K. Triphasic developmentally guided protocol to generate retinal pigment epithelium from induced pluripotent stem cells. STAR Protoc. 2022;3(3) PubMed PMC
Lytvynchuk L., Ebbert A., Studenovska H., et al. Subretinal implantation of human primary RPE cells cultured on nanofibrous membranes in minipigs. Biomedicines. 2022;10(3):669. PubMed PMC
Artero-Castro A., Long K., Bassett A., et al. Gene correction recovers phagocytosis in retinal pigment epithelium derived from retinitis pigmentosa-human-induced pluripotent stem cells. Int J Mol Sci. 2021;22(4):2092. PubMed PMC